CS
BLUE

Candriam SCA’s bluebird bio BLUE Stock Holding History

Candriam SCA’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32,663
Closed -$17.6M – 900
2021
Q1 		$17.6M Sell
32,663
-1
-0% -$492 0.15% 155
2020
Q4 		$18.3M Buy
32,664
+7,215
+28% +$4.57M 0.14% 156
2020
Q3 		$17.8M Sell
25,449
-6,770
-21% -$5.28M 0.17% 148
2020
Q2 		$25.5M Buy
32,219
+13,856
+75% +$10.4M 0.27% 97
2020
Q1 		$20.4M Buy
18,363
+2
+0% +$1.95K 0.23% 98
2019
Q4 		$20.9M Buy
18,361
+5,306
+41% +$5.77M 0.22% 98
2019
Q3 		$15.5M Hold
13,055
– – 0.21% 115
2019
Q2 		$21.4M Hold
13,055
– – 0.27% 81
2019
Q1 		$26.6M Hold
13,055
– – 0.34% 58
2018
Q4 		$16.8M Buy
13,055
+5,057
+63% +$7.76M 0.26% 87
2018
Q3 		$15.1M Buy
7,998
+2,934
+58% +$6.06M 0.2% 118
2018
Q2 		$10.3M Buy
5,064
+2,208
+77% +$5.03M 0.16% 165
2018
Q1 		$6.32M Sell
2,856
-386
-12% -$982K 0.11% 239
2017
Q4 		$7.48M Sell
3,242
-1,236
-28% -$2.51M 0.13% 199
2017
Q3 		$7.97M Sell
4,478
-3,088
-41% -$4.31M 0.14% 181
2017
Q2 		$10.3M Sell
7,566
-4,863
-39% -$5.87M 0.19% 140
2017
Q1 		$14.6M Buy
12,429
+1,853
+18% +$1.89M 0.28% 92
2016
Q4 		$8.45M Buy
10,576
+7,874
+291% +$6.25M 0.19% 138
2016
Q3 		$2.37M Sell
2,702
-695
-20% -$503K 0.06% 326
2016
Q2 		$1.91M Sell
3,397
-1,119
-25% -$634K 0.05% 321
2016
Q1 		$2.47M Buy
4,516
+23
+0.5% +$14.1K 0.06% 291
2015
Q4 		$3.74M Buy
4,493
+1,081
+32% +$1.08M 0.1% 217
2015
Q3 		$3.78M Sell
3,412
-834
-20% -$1.52M 0.09% 239
2015
Q2 		$9.26M Buy
4,246
+540
+15% +$1.1M 0.19% 150
2015
Q1 		$5.8M Sell
3,706
-231
-6% -$305K 0.12% 231
2014
Q4 		$4.68M Buy
+3,937
New +$2.63M 0.1% 243

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Candriam SCA's BLUE Position: Q2 2021 in Review

Candriam SCA sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 32,663 shares — an estimated $17.6M sold.

Candriam SCA first reported a position in BLUE in Q4 2014 and held it in 26 quarters. The position peaked at $26.6M in Q1 2019. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Candriam SCA reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Candriam SCA sold 32,663 bluebird bio shares in Q2 2021, an estimated $17.6M.
  • Candriam SCA first reported a position in bluebird bio in Q4 2014 and held it in 26 quarters.
  • Candriam SCA's bluebird bio position peaked at $26.6M in Q1 2019.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.